Belantamab mafodotin, a BCMA-targeting ADC, is approved for relapsed/refractory multiple myeloma after two prior therapies, showing significant PFS and OS benefits in the DREAMM-7 trial. The drug ...

Nomad has launched its latest Apple Watch accessory, the Stratos Band. It combines lightweight and durable titanium with FKM rubber for a breathable, comfortable, and durable watch band, unlike ...

The Cincinnati Bengals shared their NFL Week 8 uniform combo for their game Oct. 26 against the 0-7 New York Jets, declaring on social media that they're "getting in the Halloween spirit" with a black ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...

The trial has shown curability of the combination over a five-year period. Image credit: Nemes Laszlo / Shutterstock.com MSD and Eisai’s combination of Keytruda (pembrolizumab) and Lenvima (lenvatinib ...

As per data presented at the European Society for Medical Oncology (ESMO) 2025 Congress, the Phase III ENGOT-ov65/KEYNOTE-B96 study with Keytruda met the primary endpoint of progression-free survival ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

Following a strong early showing of Tecvayli and Darzalex Faspro in newly diagnosed multiple myeloma patients last month, Johnson & Johnson is making the case for its oncology cocktail as a potential ...

While the original Arkanoid was a simple game, we cannot say the same thing about BALL x PIT. Its foundation is indeed not very complex, though when we add all the balls available in the game and mix ...